Skip to main content
Signal8

Vickers Philip J.

SEC insider (Form 3/4/5 filer). CIK 0001635046. Director at Akebia Therapeutics, Inc. (AKBA). 1 reported Form 4/5 transaction since Sep 2024; latest on Apr 1, 2026. Located in CAMBRIDGE, MA.

Companies Vickers Philip J. has filed insider reports for

  • Akebia Therapeutics, Inc. (AKBA): Director
Vickers Philip J. profile photo

Vickers Philip J.

CIK: 0001635046

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Akebia Therapeutics, Inc. logo
AKBA

Akebia Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (1 total)

  • Akebia Therapeutics, Inc. logo
    AKBA

    Akebia Therapeutics, Inc.

    Apr 1, 2026
    Award

    Stock Option (Right to buy)

    Direct
    214.4K shares-

1-1 of 1